Skip to main content

Table 2 5-year survival rates (SR) and statistical analyses for comparison of distinct groups of colon cancer patients.

From: Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas

Variable

5-year SR

95% CI

p-value (comparison)

 

Metastasis

    

   yes (TM+)

73%

68-77%

< 0.0001

 

   no (TM-)

21%

13-31%

  

Grading

   1

73%

37-90%

0,6578 (1 vs 2)

 

   2

67%

61-72%

 

0.1449 (1 vs 3)

   3

52%

41-61%

0.0113 (2 vs 3)

 

N-stage

   0

66%

60-71%

0.7206 (0 vs 1)

 

   1

64%

53-73%

 

0.0230 (0 vs 2)

   2

49%

35-62%

0.0790 (1 vs 2)

 

UICC stage

   I

80%

71-87%

0,0001 (I vs II)

 

   II

59%

51-66%

 

0.0002 (I vs III)

   III

59%

50-66%

0.9928 (II vs III)

 

Localization

    

   right

59%

52-65%

0.0512

 

   left

68%

61-74%

  
  1. "Metastasis"implies the occurrence of a distant metastasis within a 5-year interval after primary surgery. 5-year SR: 5-year survival rate; 95% CI: 95% confidence interval. α = 0.05. Significant p-values are highlighted in bold